世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のセルフリーDNA(cfDNA)検査市場予測 2018-2026年

GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET FORECAST 2018-2026

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年8月US$2,500
シングルユーザライセンス(印刷不可PDF)
145

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界のセルフリーDNA(cfDNA)検査市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS

The global cell-free DNA (cfDNA) testing market is anticipated to register a CAGR of 18.52% between the forecasted years of 2018-2026. Factors such as the global increase in the number of people suffering from chronic diseases, advances in molecular pathogenesis and a surge in prenatal complication are increasing the market demand for cell-free DNA testing.

MARKET INSIGHTS

The Global Cell-free DNA (cfDNA) testing market is segmented on the basis of products, platforms and applications. The product segment of this market includes automated instruments, consumables and extraction/isolation kits. The extraction isolation kits can be either magnetic bead-based, column-based or other extraction/isolation kits. The various platforms for the cell-free DNA testing market are NGS, rPCR and multiplexed PCR, qPCR, dPCR and other platform. The market chiefly finds its application in areas like oncology, NIPT and other disease conditions.

REGIONAL INSIGHTS

Regional segmentation of the global cell-free DNA market is done into Asia-Pacific, Europe, North America, and rest of the world. The North American market is likely to account for the highest revenue share by the end of the forecast period of 2018-2026. The growing prevalence of cancer is increasing the demand for cell-free DNA tests. These tests are also being employed in prenatal screening.
COMPETITIVE INSIGHTS
The leading companies operating in this market are Agilent Technologies Inc, Accubiomed, Aline Biosciences, Berry Genomics, Bioo Scientific Corporation, F. Hoffmann-La Roche Ltd, Gatc Biotech Ag. (Acquired By Eurofins Scientific), Illumina, Laboratory Corporation Of America, Merck Kgaa, Natera Inc, Nipd Genetics, Premaitha Health Plc, Qiagen N.V, and Thermo Fisher Scientific Inc.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. SWELLING SAMPLE NUMBERS FOR SCREENING AND DIAGNOSTICS USING CIRCULATING CELL-FREE DNA (CFFDNA)
3.2.2. AUTOMATED INSTRUMENTS ARE ANTICIPATED TO GROW SIGNIFICANTLY IN TERMS OF PRODUCTS
3.2.3. NEXT GENERATION SEQUENCING PLATFORM HOLDS THE LARGEST MARKET SHARE
3.2.4. NIPT IS THE MAJORLY USED APPLICATION IN THE CFDNA TESTING MARKET
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCREASING THE RISK OF CHRONIC DISEASES DUE TO UNHEALTHY LIFESTYLE
4.1.2. ADVANCES IN MOLECULAR PATHOGENESIS
4.1.3. RISING PARASITIC INFECTION
4.1.4. SURGE IN PRENATAL COMPLICATION
4.1.5. AWARENESS FOR PRENATAL TESTING
4.2. MARKET RESTRAINTS
4.2.1. HIGH COST OF TREATMENT
4.2.2. SHORTAGE OF SKILLED PROFESSIONALS
4.3. MARKET OPPORTUNITIES
4.3.1. INCREASING COLLABORATIONS AND PARTNERSHIPS BETWEEN THE COMPANIES
4.3.2. SCOPE FOR PERSONALIZED MEDICINES
4.3.3. TECHNOLOGICAL ADVANCEMENT
4.4. MARKET CHALLENGES
4.4.1. REIMBURSEMENT ISSUES
4.4.2. SOCIAL, LEGAL AND ETHICAL ISSUES
5. MARKET SEGMENTATION
5.1. MARKET BY PRODUCTS 2018-2026
5.1.1. AUTOMATED INSTRUMENTS
5.1.2. CONSUMABLES
5.1.3. EXTRACTION/ISOLATION KITS
5.1.3.1. MAGNETIC BEAD BASED
5.1.3.2. COLUMN BASED
5.1.3.3. OTHER EXTRACTION/ISOLATION KITS
5.2. MARKET BY PLATFORM 2018-2026
5.2.1. NGS
5.2.2. RPCR AND MULTIPLEXED PCR
5.2.3. QPCR
5.2.4. DPCR
5.2.5. OTHER PLATFORM
5.3. MARKET BY APPLICATION 2018-2026
5.3.1. ONCOLOGY
5.3.2. NIPT
5.3.3. OTHER DISEASE CONDITIONS
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. ETYMOLOGY OF CFDNA
6.3. PRICING ANALYSIS
6.4. BIOLOGICAL ROLE OF CFDNA
6.5. APPLICATION OF CIRCULATING CELL-FREE DNA
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. THE UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. THE UNITED KINGDOM
7.2.2. GERMANY
7.2.3. FRANCE
7.2.4. ITALY
7.2.5. SPAIN
7.2.6. RUSSIA
7.2.7. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. AUSTRALIA
7.3.4. INDIA
7.3.5. SOUTH KOREA
7.3.6. REST OF ASIA PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST AND AFRICA
8. COMPANY PROFILES
8.1. COMPETITIVE LANDSCAPE
8.1.1. MARKET SHARE ANALYSIS
8.2. AGILENT TECHNOLOGIES INC.
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVE
8.3. ACCUBIOMED
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.4. ALINE BIOSCIENCES
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.5. BERRY GENOMICS
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. BIOO SCIENTIFIC CORPORATION
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.7. F. HOFFMANN-LA ROCHE LTD
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. GATC BIOTECH AG. (ACQUIRED BY EUROFINS SCIENTIFIC)
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVES
8.9. ILLUMINA
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC INITIATIVES
8.10. LABORATORY CORPORATION OF AMERICA
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVES
8.11. MERCK KGAA
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVES
8.12. NATERA INC.
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.12.4. STRATEGIC INITIATIVES
8.13. NIPD GENETICS
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.14. PREMAITHA HEALTH PLC
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.15. QIAGEN N.V.
8.15.1. COMPANY OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. SCOT ANALYSIS
8.15.4. STRATEGIC INITIATIVES
8.16. THERMO FISHER SCIENTIFIC, INC.
8.16.1. COMPANY OVERVIEW
8.16.2. PRODUCT PORTFOLIO
8.16.3. SCOT ANALYSIS
8.16.4. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 (THOUSAND UNITS)
TABLE 3 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PRODUCTS 2018-2026 (THOUSAND UNITS)
TABLE 5 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS BY METHODS 2018-2026 ($ MILLION)
TABLE 6 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS BY METHODS 2018-2026 (THOUSAND UNITS)
TABLE 7 COMMERCIALLY AVAILABLE ISOLATION KITS
TABLE 8 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PLATFORM 2018-2026 ($ MILLION)
TABLE 9 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PLATFORM 2018-2026 (THOUSAND UNITS)
TABLE 10 NEXT GENERATION SEQUENCING (NGS) AND POLYMERASE CHAIN REACTION (DPCR) COMPARISON
TABLE 11 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 12 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY APPLICATION 2018-2026 (THOUSAND UNITS)
TABLE 13 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 (THOUSAND UNITS)
TABLE 15 NORTH AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 16 NORTH AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 17 EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 18 EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 19 ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 21 REST OF WORLD CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 22 REST OF WORLD CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)


FIGURES LIST
FIGURE 1 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 2 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 3 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN AUTOMATED INSTRUMENTS 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN AUTOMATED INSTRUMENTS 2018-2026 (THOUSAND UNITS)
FIGURE 5 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN CONSUMABLES 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN CONSUMABLES 2018-2026 (THOUSAND UNITS)
FIGURE 7 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS 2018-2026 (THOUSAND UNITS)
FIGURE 9 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN MAGNETIC BEAD BASED 2018-2026 (THOUSAND UNITS)
FIGURE 10 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN MAGNETIC BEAD BASED 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN COLUMN BASED 2018-2026 (THOUSAND UNITS)
FIGURE 12 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN COLUMN BASED 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN OTHER EXTRACTION/ISOLATION KITS 2018-2026 (THOUSAND UNITS)
FIGURE 14 GLOBAL EXTRACTION/ISOLATION KITS MARKET IN OTHER EXTRACTION/ISOLATION KITS 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN NGS 2018-2026 ($ MILLION)
FIGURE 16 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN NGS 2018-2026 (THOUSAND UNITS)
FIGURE 17 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN RPCR AND MULTIPLEXED PCR 2018-2026 ($ MILLION)
FIGURE 18 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN RPCR AND MULTIPLEXED PCR 2018-2026 (THOUSAND UNITS)
FIGURE 19 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN QPCR 2018-2026 ($ MILLION)
FIGURE 20 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN QPCR 2018-2026 (THOUSAND UNITS)
FIGURE 21 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN DPCR 2018-2026 ($ MILLION)
FIGURE 22 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN DPCR 2018-2026 (THOUSAND UNITS)
FIGURE 23 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN OTHER PLATFORM 2018-2026 ($ MILLION)
FIGURE 24 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN OTHER PLATFORM 2018-2026 (THOUSAND UNITS)
FIGURE 25 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN ONCOLOGY 2018-2026 ($ MILLION)
FIGURE 26 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN ONCOLOGY 2018-2026 (THOUSAND UNITS)
FIGURE 27 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN NIPT 2018-2026 ($ MILLION)
FIGURE 28 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN NIPT 2018-2026 (THOUSAND UNITS)
FIGURE 29 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN OTHER DISEASE CONDITIONS 2018-2026 ($ MILLION)
FIGURE 30 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN OTHER DISEASE CONDITIONS 2018-2026 (THOUSAND UNITS)
FIGURE 31 THE UNITED STATES CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 32 THE UNITED STATES CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 33 CANADA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 34 CANADA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 35 THE UNITED KINGDOM CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 36 THE UNITED KINGDOM CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 37 GERMANY CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 38 GERMANY CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 39 FRANCE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 40 FRANCE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 41 ITALY CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 42 ITALY CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 43 SPAIN CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 44 SPAIN CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 45 RUSSIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 46 RUSSIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 47 REST OF EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 48 REST OF EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 49 CHINA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 50 CHINA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 51 JAPAN CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 52 JAPAN CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 53 AUSTRALIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 54 AUSTRALIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 55 INDIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 56 INDIA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 57 SOUTH KOREA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 58 SOUTH KOREA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 59 REST OF ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 60 REST OF ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 61 LATIN AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 62 LATIN AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 63 MIDDLE EAST AND AFRICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
FIGURE 64 MIDDLE EAST AND AFRICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
FIGURE 65 COMPANY MARKET SHARE ANALYSIS OF CFDNA TESTING MARKET 2017 (%)

List of Tables

TABLE LIST
TABLE 1 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 (THOUSAND UNITS)
TABLE 3 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PRODUCTS 2018-2026 (THOUSAND UNITS)
TABLE 5 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS BY METHODS 2018-2026 ($ MILLION)
TABLE 6 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET IN EXTRACTION/ISOLATION KITS BY METHODS 2018-2026 (THOUSAND UNITS)
TABLE 7 COMMERCIALLY AVAILABLE ISOLATION KITS
TABLE 8 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PLATFORM 2018-2026 ($ MILLION)
TABLE 9 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY PLATFORM 2018-2026 (THOUSAND UNITS)
TABLE 10 NEXT GENERATION SEQUENCING (NGS) AND POLYMERASE CHAIN REACTION (DPCR) COMPARISON
TABLE 11 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 12 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY APPLICATION 2018-2026 (THOUSAND UNITS)
TABLE 13 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET BY GEOGRAPHY 2018-2026 (THOUSAND UNITS)
TABLE 15 NORTH AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 16 NORTH AMERICA CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 17 EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 18 EUROPE CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 19 ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 20 ASIA PACIFIC CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)
TABLE 21 REST OF WORLD CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 ($ MILLION)
TABLE 22 REST OF WORLD CELL-FREE DNA (CFDNA) TESTING MARKET 2018-2026 (THOUSAND UNITS)

Companies Mentioned

1. AGILENT TECHNOLOGIES INC.
2. ACCUBIOMED
3. ALINE BIOSCIENCES
4. BERRY GENOMICS
5. BIOO SCIENTIFIC CORPORATION
6. F. HOFFMANN-LA ROCHE LTD
7. GATC BIOTECH AG. (ACQUIRED BY EUROFINS SCIENTIFIC)
8. ILLUMINA
9. LABORATORY CORPORATION OF AMERICA
10. MERCK KGAA
11. NATERA INC.
12. NIPD GENETICS
13. PREMAITHA HEALTH PLC
14. QIAGEN N.V.
15. THERMO FISHER SCIENTIFIC, INC.

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る